Skip to main content
Log in

Electroconvulsive therapy in Parkinson's syndrome with “on-off” phenomenon

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

During long-term treatment with L-dopa in Parkinson's syndrome “on-off” phenomenon develops in many cases, often entailing considerable therapeutic problems. Decreased sensitivity in postsynaptic striatal dopamine (DA) receptors has been shown to occur in parkinsonian patients during long-term treatment with L-dopa. This has been suggested as one possible mechanism for development of the “on-off” phenomenon. In contrast to L-dopa treatment electroconvulsions have been shown to increase sensitivity in the DA receptors, when administered to animals.

The antiparkinsonian effect of electroconvulsive therapy (ECT) was investigated in five parkinsonian patients with “on-off” phenomenon, with or without concomitant signs of mental depression. ECT was administered according to praxis in treatment of mental depression. Drug therapy, including L-dopa, was maintained on previously adjusted doses during and after ECT.

A marked improvement in the parkinsonian symptoms as well as in the “on-off” phenomenon occurred in three of the patients, persisting for several months. The other two patients showed only slight and transient improvement.

It thus seems that ECT may be useful as a supplementary treatment in parkinsonian patients with “on-off” phenomenon. The antiparkinsonian effect of ECT is probably mediated by increased sensitivity in postsynaptic DA structures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian, G. K., Bunney, B. S.: Pre- and postsynaptic feedback mechanisms in central dopaminergic neurons. In: Frontiers in Neurology and Neuroscience Research 1974. First International Symposium of the Neuroscience Institute, University of Toronto (Seeman, P., Brown, G. M., eds.), pp. 4–11.

  • Andén, N.-E., Stock, G. Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol.279, 89–92 (1973).

    Google Scholar 

  • Asnis, G. Parkinson's disease, depression, and ECT: A review and case study. Am. J. Psychiat.134, 191–195 (1977).

    PubMed  Google Scholar 

  • Åsberg, M., Kragh-Sørensen, P., Mindham, R. H. S., Tuck, R. J. International reliability and communicability of a rating scale for depression. Psychol. Med.3, 458–465 (1973).

    PubMed  Google Scholar 

  • Barbeau, A. Long-term side-effects of levodopa. Lanceti, 395 (1971).

    Google Scholar 

  • Bergstrom, D. A., Treiser, S., Kellar, K. J.: Electroconvulsive shocks: Effects on monoaminergic receptor binding in rat brain. In: Catecholamines: Basic and Clinical Frontiers, Abstract 180. 4th International Catecholamine Symposium, September 17–22, 1978, Pacific Grove, California.

  • Berlet, H. H. Aspects of amino acid metabolism in phenylketonuria and other amino acidopathies. In: Progress in Brain Research (Himwich, W. A., Schade, J. P., eds.), Vol. 16, pp. 184–213. Amsterdam-London-New York: Elsevier. 1965.

    Google Scholar 

  • Birkmayer, W., Riederer, P., Rausch, W. D.: (−)Deprenyl and nomifensine in the treatment of Parkinson's disease and depressive syndrome. 4th International Catecholamine Symposium, September 17–22, 1978, Pacific Grove, California. Abstract no. 556.

  • Bolwig, T. G., Hertz, M. M., Holm-Jensen, J. Blood-brain barrier permeability during electroshock seizures in the rat. European J. Clin. Invest.7, 95–100 (1977).

    Google Scholar 

  • Calne, D. B., Claveria, L. E., Allen, J. G. Plasma levodopa and the “on-off” effect. Adv. Neurol.5, 341–344 (1974).

    PubMed  Google Scholar 

  • Carlsson, A., Granérus, A.-K., Svanborg, A.: The ageing neuron-influence on symptomatology and therapeutic response in Parkinson's syndrome. Adv. Neurol. (to be published, 1979).

  • Cronholm, B., Ottosson, J.-O. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression: The role of electric stimulation and of the seizure studied by variation of stimulus and modification by lidocaine of seizure discharge. Acta Psychiatr. Neurol. Scand.35 (suppl. 145), 69–97 (1960).

    Google Scholar 

  • Edén, S., Modigh, K. Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Research129, 379–384 (1977).

    PubMed  Google Scholar 

  • Evans, J. P. M., Grahame-Smith, D. G., Green, A. R., Tordoff, A. F. C. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br. J. Pharmac.56, 193–199 (1976).

    Google Scholar 

  • Granérus, A.-K. L-Dopa treatment in Parkinson's syndrome, pp. 1–32. Kungälv, Sweden: Gotab. 1977.

    Google Scholar 

  • Granérus, A.-K. Factors influencing the occurrence of “on-off” symptoms during long-term treatment with L-dopa. Acta Med. Scand.203, 75–85 (1978).

    PubMed  Google Scholar 

  • Granérus, A.-K., Steg, G., Svanborg, A. Clinical analysis of factors influencing L-dopa treatment of Parkinson's syndrome. Acta Med. Scand.192, 1–11 (1972).

    PubMed  Google Scholar 

  • Green, A. R., Heal, D. J., Grahame-Smith, D. G. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology52, 195–200 (1977).

    PubMed  Google Scholar 

  • Green, A. R., Peralta, E., Hong, J. S., Mao, C. C., Atterwill, C. K., Costa, E. Alterations in GABA metabolism and met-enkephalin content in rat brain following repeated electroconvulsive shocks. J. Neurochem.31, No. 3, 607 (1978).

    PubMed  Google Scholar 

  • Guroff, G., Udenfriend, S. Studies on aromatic amino acid uptake by rat brainin vivo. J. Biol. Chem.237, 803–806 (1962).

    PubMed  Google Scholar 

  • Lebensohn, Z. M., Jenkins, R. B. Improvement of parkinsonism in depressed patients treated with ECT. Am. J. Psychiat.132, 283–285 (1975).

    PubMed  Google Scholar 

  • Lee, T., Seeman, P., Rajput, A., Farley, I. J., Hornykiewicz, O. Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature273, 59–61 (1978).

    PubMed  Google Scholar 

  • Longoni, R., Mulas, A., Oderfeld, B., Marconcini Pepeu, I., Pepeu, G. Effect of single and repeated electroshock applications on brain acetylcholine levels and choline acetyltransferase activity in the rat. Neuro-pharmacology15, 283–286 (1976).

    Google Scholar 

  • Markham, C. G. The “on-off” side effect of L-dopa. Adv. Neurol.5, 387–396 (1974).

    PubMed  Google Scholar 

  • Modigh, K. Correlation between clinical effects of various antidepressant treatments and their effects on monoaminergic receptors in the brain. In: Neuropsychopharmacology (Deniker, P., Radouco-Thomas, C., Villeneuve, A., eds.), pp. 739–797. Oxford-New York: Pergamon Press. 1978.

    Google Scholar 

  • Modigh, K. Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J. Neural Transm.36, 19–32 (1975).

    PubMed  Google Scholar 

  • Modigh, K. Long-term effects of electroconvulsive shock therapy on synthesis turnover and uptake of brain monoamines. Psychopharmacology49, 179–185 (1976).

    PubMed  Google Scholar 

  • Nagatsu, T., Kato, T., Lizuka, R., Narabayashi, H.: Catecholamine enzymes in Parkinson's disease. In: 4th International Catecholamine Symposium, September 17–22, 1978, Pacific Grove, California. Abstract no. 598.

  • Praag, H. M. van, Korf, J., Lakke, J. P. W. F., Schut, T. Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychol. Med.5, 138–146 (1975).

    PubMed  Google Scholar 

  • Price, K. S., Farley, I. J., Hornykiewicz, O. Neurochemistry of Parkinson's disease: Relation between striatal and limbic dopamine. In: Advances in Biochemical Psychopharmacology (Roberts, P. J., et al., eds.), Vol. 19, pp. 293–300. New York: Raven Press. 1978.

    Google Scholar 

  • Pryor, G. T. Effect of repeated ECS on brain weight and brain enzymes. In: Psychobiology of Convulsive Therapy (Fink, M., Kety, S., McGaugh, J., Williams, T. A., eds.). Washington, D.C.: V. H. Winston & Sons. 1974.

    Google Scholar 

  • Randrup, A., Braestrup, C. Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression. Psychopharmacology53, 309–314 (1977).

    PubMed  Google Scholar 

  • Sweet, R. D., McDowell, F. H. The “on-off” response to chronic L-dopa treatment of parkinsonism. Adv. Neurol.5, 331–338 (1974).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balldin, J., Edén, S., Granérus, A.K. et al. Electroconvulsive therapy in Parkinson's syndrome with “on-off” phenomenon. J. Neural Transmission 47, 11–21 (1980). https://doi.org/10.1007/BF01256635

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01256635

Keywords

Navigation